AI assistant
Sending…
Alkermes plc. — Director's Dealing 2025
Feb 28, 2025
31048_dirs_2025-02-28_44de08c7-df52-4f3c-afcf-947030f2f95a.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Alkermes plc. (ALKS)
CIK: 0001520262
Period of Report: 2025-02-26
Reporting Person: Hopkinson Craig C. (EVP R&D, Chief Medical Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-02-26 | Ordinary Shares | M | 6866 | — | Acquired | 80789 | Direct |
| 2025-02-26 | Ordinary Shares | F | 3049 | $34.795 | Disposed | 77740 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2025-02-26 | Restricted Stock Unit Award | $ | M | 6866 | Disposed | Ordinary Shares (6866) | Direct |
Footnotes
F1: Each restricted stock unit represents a contingent right to receive one ordinary share.
F2: Shares subject to the restricted stock unit award vest in four equal annual installments, commencing on 2/26/2025.
More from Alkermes plc.
Regulatory Filings
2026
May 20
Regulatory Filings
2026
May 12
Regulatory Filings
2026
May 5
Regulatory Filings
2026
May 1
Annual Report
2026
Apr 6
Proxy Solicitation & Information Statement
2026
Apr 6
Regulatory Filings
2026
Mar 27
Major Shareholding Notification
2026
Mar 26
Director's Dealing
2026
Feb 27
Director's Dealing
2026
Feb 27